Vol. 2, Issue Supplement 2, 2022
(S19-42)
2022 Precision Oncology Conference Abstracts
Tumor genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation (UCS) compared to pure urothelial carcinoma (UC)
Nishita Tripathi, Yeonjung Jo, Nicolas Sayegh, Haoran Li, Roberto Nussenzveig, Benjamin Haaland, Sumati Gupta, Umang Swami, Petros Grivas, Neeraj Agarwal, Deepika Sirohi
Conference AbstractsPublished on: 25 Oct 2022
Overall survival (OS) after progression on first novel hormonal therapy (NHT) in patients (pts) with metastatic castration-sensitive versus castration-resistant prostate cancer (mCSPC versus mCRPC)
Nicolas Sayegh, Nishita Tripathi, Adam Kessel, Roberto Nussenzveig, Beverly Chigarira, Haoran Li, Clara Tandar, Divyam Goel, Blake Nordblad, Jackson Cheney, Umang Swami, Neeraj Agarwal
Conference AbstractsPublished on: 25 Oct 2022
Transcriptomic profiling of patients (pts) with de-novo metastatic castration-sensitive prostate cancer (DN-mCSPC) versus those with mCSPC that have relapsed from prior localized therapy (PLT-mCSPC)
Nicolas Sayegh, Beverly Chigarira, Haoran Li, Nishita Tripathi, Blake Nordblad, Divyam Goel, Clara Tandar, Marc Yandell, Roberto Nussenzveig, Deepika Sirohi, Umang Swami, Neeraj Agarwal
Conference AbstractsPublished on: 20 Oct 2022
Genetic mutation profile in HER2 positive lobular breast cancer
Suman Gaire, Pravash Budhathoki, Utsav Joshi, Anish K. Shah, Siddhartha Yadav
Conference AbstractsPublished on: 20 Oct 2022
Access to Care and Health Care Quality Metrics in Urban Versus Rural Patients With Advanced Genitourinary Cancers
Haoran Li, Nishita Tripathi, Nicolas Sayegh, Jackson Cheney, Blake Nordblad, Beveerly Chigarira, Umang Swami, Sumati Gupta, Neeraj Agarwal
Conference AbstractsPublished on: 20 Oct 2022
Tumor genomic landscape in smokers compared to non-smoker patients with locally advanced or metastatic urothelial carcinoma
Nishita Tripathi, Nicolas Sayegh, Yeonjung Jo, Haoran Li, Roberto Nussenzveig, Benjamin Haaland, Sumati Gupta, Deepika Sirohi, Umang Swami, Neeraj Agarwal
Conference AbstractsPublished on: 20 Oct 2022
Genomic characterization of patients (pts) with de-novo high-volume metastatic castration-sensitive prostate cancer (dn-hv-mCSPC) compared to those without dn-hv-mCSPC.
Nicolas Sayegh, Yeonjung Jo, Nishita Tripathi, Adam Kessel, Roberto Nussenzveig, Beverly Chigarira, Haoran Li, Clara Tandar, Benjamin Haaland, Umang Swami, Neeraj Agarwal
Conference AbstractsPublished on: 20 Oct 2022
Survival outcomes and characterization of patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) undergoing intensified androgen deprivation therapy (ADT) who do not achieve an optimal PSA response (PSA ≤0.2 ng/mL).
Nicolas Sayegh, Nishita Tripathi, Beverly Chigarira, Yeonjung Jo, Adam Kessel, Roberto Nussenzveig, Haoran Li, Clara Tandar, Divyam Goel, Benjamin Haaland, Umang Swami, Neeraj Agarwal
Conference AbstractsPublished on: 20 Oct 2022
Progression-free survival (PFS) and overall survival (OS) in patients (pts) with de-novo, high-volume metastatic castration-sensitive prostate cancer (dn-hv-mCSPC) undergoing intensified androgen deprivation therapy (ADT)
Umang Swami, Beverly Chigarira, Nicolas Sayegh, Nishita Tripathi, Roberto Nussenzveig, Adam Kessel, Clara Tandar, Divyam Goel, Jackson Cheney, Blake Nordblad, Deepika Sirohi, Neeraj Agarwal
Conference AbstractsPublished on: 20 Oct 2022
Analysis of genetic alterations of DNA repair genes as prognostic marker of survival in cholangiocarcinoma
Utsav Joshi, Roshan Subedi, Niraj Neupane, Pravash Budhathoki, Suman Gaire, Anish K. Shah, Aashish Acharya, Vishakha Agrawal, Siddhartha Yadav
Conference AbstractsPublished on: 12 Oct 2022
Trilaciclib Use and Chemotherapy-Induced Myelosuppression Among Patients with ES- SCLC in US Community Oncology Settings
Jerome Goldschmidt, Alisha Monnette, Ping Shi, Divea Venkatasetty, Lorena Lopez-Gonzalez, Huan Huang
Conference AbstractsPublished on: 12 Oct 2022
Evaluation of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small Cell Lung Cancer Treated with Trilaciclib: Retrospective Analysis of Florida Community Oncology Practices
Lowell Hart, Augustina Ogbonnaya, Kristen Boykin, Kathryn Deyoung, Ray Bailey, Trevor Heritage, Lorena Lopez-Gonzalez, Huan Huang, Lucio Gordan
Conference AbstractsPublished on: 12 Oct 2022
Circulating Tumor Cell cluster phenotype and response to treatment and predicts survival in lung cancer
Prashanth Kumar, Annapoorni Rangarajan
Conference AbstractsPublished on: 12 Oct 2022
Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Non-Small Cell Lung Cancer (NSCLC)
Christopher Thompson
Conference AbstractsPublished on: 12 Oct 2022
Serial Monitoring of circulating tumor DNA (ctDNA) reliably detects progression and regression in lung cancer patients
Ujjwal Karki, Bipin Ghimire, Emma Herrman
Conference AbstractsPublished on: 06 Oct 2022
Scroll for more